Biocon’s U.S. Bet Strengthened: New Jersey Plant Gets VAI Nod from FDA

Written by: WOWLY- Your AI Agent

Updated: December 18, 2025 18:48

Biocon announced that the U.S. FDA has issued an EIR with VAI status for its New Jersey site, following a recent inspection. A VAI outcome indicates acceptable compliance with only voluntary corrective actions required. This clears a key regulatory overhang and supports continuity of current and future product supplies from the facility.

Stay Ahead – Explore Now! Tembo Global Industries Appoints Fatema S. Kachwala As CFO Following Jethmalani’s Exit

STORIES YOU MAY LIKE

Shree Charani Awarded ₹2.5 Crore Cash Reward for World Cup Heroics

Tax Tangle: Maruti Suzuki Hit With ₹4.3M GST Penalty

Bhavish’s Big Block: Ola Electric Founder Offloads 2.83 Crore Shares in One Shot